Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
More frequent hearing aid use could help stave off dementia, experts suggest
By
Aaron Dorman
Jan 08, 2024
Newly available non-prescription hearing aid use could have major overall health benefits and reduce the risk of dementia, experts say.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
Visionary Alzheimer’s forecasting software gets FDA approval
By
Aaron Dorman
Jan 30, 2024
A newly regulated Alzheimer’s software tool offers clarity on whether the condition is likely to progress to dementia in someone with mild cognitive impairment.
New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
AI-driven speech analysis firm working to diagnose Alzehimer’s, Huntington’s
By
Aaron Dorman
Jun 27, 2023
A speech analysis software company is using Voice AI to diagnose depression and anxiety, and diseases like Alzheimer’s and Huntington’s could be next.
Several states consider requiring adult changing stations in certain buildings
By
Lois A. Bowers
Feb 03, 2020
Legislators in several states are considering requiring adult changing stations to be installed in certain locations to benefit caregivers and older adults living with Alzheimer’s disease, those who...
Poor sleep, daytime napping could be signs of Alzheimer’s
By
Lois A. Bowers
Jan 10, 2019
Poor-quality sleep could be an early sign of Alzheimer’s disease in older adults, according to the findings of a new study, published Jan. 9 in the journal Science Translational Medicine.
AI ‘can’t fly solo,’ needs humanizing context for use in healthcare, data expert emphasizes
By
Aaron Dorman
Oct 10, 2023
A researcher who builds passive AI-enabled monitoring devices believes that if more people adopted tech, it could provide invaluable data.
Can we please quit calling them Alzheimer’s patients?
By
John O'Connor
Mar 31, 2016
With all due respect to Alzheimer’s, the brand needs an overhaul.